Dopamine-induced reduction in the density of guanine nucleotide-sensitive D1 receptors in human postmortem brain in the absence of apparent D1: D2 interactions

Neuropharmacology. 1995 Jul;34(7):777-83. doi: 10.1016/0028-3908(95)00039-9.

Abstract

The effects of dopamine and guanine nucleotides on the binding of the D1 dopamine receptor antagonist ligand [3H]SCH 23390 were examined in membranes prepared from putamen, caudate and nucleus accumbens of human postmortem brain. Dopamine induced a concentration-dependent decrease in the apparent maximum number of binding sites (Bmax) in each brain region studied, and displaced binding in a biphasic manner consistent with the presence of both high and low affinity states of the D1 receptor; the GTP analogue Gpp(NH)p transformed this biphasic displacement to a monophasic pattern consistent with a shift of high affinity sites to a low affinity state. However, the selective D2 antagonist eticlopride did not reverse the action of dopamine to decrease Bmax. These data suggest that dopamine decreases Bmax for D1 receptors through a high affinity, guanine nucleotide-sensitive agonist binding site, but fail to reveal D1:D2 interactions at this synaptic level.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autopsy
  • Benzazepines / pharmacology
  • Binding, Competitive
  • Brain / drug effects*
  • Brain / metabolism
  • Caudate Nucleus / drug effects
  • Dopamine / pharmacology*
  • Dose-Response Relationship, Drug
  • Female
  • Guanine Nucleotides / pharmacology*
  • Humans
  • Male
  • Middle Aged
  • Nucleus Accumbens / drug effects
  • Putamen / drug effects
  • Receptors, Dopamine D1 / drug effects*
  • Receptors, Dopamine D1 / physiology*

Substances

  • Benzazepines
  • Guanine Nucleotides
  • Receptors, Dopamine D1
  • Dopamine